ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ESTHER VALDEZ M.D.

Psychiatry

1,861

$141K

144
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 20%

$76
Average prescription price

Avg: $110

JOSEPH AFONSO M.D.

Psychiatry

1,833

$277K

100
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 20%

$151
Average prescription price

Avg: $110

SUSAN GULESIAN MD

Psychiatry

1,831

$199K

110
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 20%

$109
Average prescription price

Avg: $110

DAVID GOLDEN M.D.

Psychiatry

1,824

$268K

119
50 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$147
Average prescription price

Avg: $110

PADMA SURESH M.D.

Psychiatry

1,823

$145K

226
115 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 20%

$80
Average prescription price

Avg: $110

KATHLEEN PETRUSKA M.D.

Psychiatry

1,814

$215K

108
14 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$118
Average prescription price

Avg: $110

MARIA ARRUBLA M.D.

Psychiatry

1,810

$284K

159
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

55%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 20%

$157
Average prescription price

Avg: $110

ZELDA VIDELEFSKY M.D.

Psychiatry

1,806

$160K

101
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$89
Average prescription price

Avg: $110

ANNETTE KAWECKI MD

Psychiatry

1,801

$183K

202
125 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$101
Average prescription price

Avg: $110

ETHEL BULLITT M.D.

Psychiatry

1,797

$188K

76
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$104
Average prescription price

Avg: $110

ROBERT CSERR M.D.

Psychiatry

1,791

$181K

98
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$101
Average prescription price

Avg: $110

PETER BRIGHAM MD

Psychiatry

1,777

$210K

70
22 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$118
Average prescription price

Avg: $110

EMILYMARIE CLIONSKY MD

Psychiatry

1,775

$484K

176
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

73%
prescriptions for brand name drugs

Avg: 20%

$273
Average prescription price

Avg: $110

MAHNOOSH ESLAMI MD

Psychiatry

1,761

$135K

174
133 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$77
Average prescription price

Avg: $110

JOHN HOWLAND MD

Psychiatry

1,755

$108K

130
42 are 65+

25%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 20%

$61
Average prescription price

Avg: $110

JEFF PALACIOS M.D.

Psychiatry

1,753

$189K

187
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$108
Average prescription price

Avg: $110

ALISON MEHTA D.O.

Psychiatry

1,747

$297K

119
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 20%

$170
Average prescription price

Avg: $110

KISHANLAL CHAKRABARTI MD

Psychiatry

1,742

$95.5K

206
0 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $110

PAOLO CASSANO MD, PHD

Psychiatry

1,729

$232K

76
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$134
Average prescription price

Avg: $110

JAMES FELDMAN M. D.

Psychiatry

1,724

$375K

100
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 20%

$217
Average prescription price

Avg: $110

FARROKH KHAJAVI-NOORI MD

Psychiatry

1,722

$158K

119
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$92
Average prescription price

Avg: $110

KENNARD KOBRIN M.D.

Psychiatry

1,717

$275K

100
0 are 65+

21%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 20%

$160
Average prescription price

Avg: $110

CARLOS NEU M.D.

Psychiatry

1,715

$186K

131
0 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$108
Average prescription price

Avg: $110

M CREMENS MD

Psychiatry

1,714

$222K

174
168 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 20%

$129
Average prescription price

Avg: $110

MARIA MELO MD

Psychiatry

1,709

$274K

130
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 20%

$160
Average prescription price

Avg: $110

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank